DK0552240T3 - Ny metode til behandling af depression - Google Patents

Ny metode til behandling af depression

Info

Publication number
DK0552240T3
DK0552240T3 DK91918381T DK91918381T DK0552240T3 DK 0552240 T3 DK0552240 T3 DK 0552240T3 DK 91918381 T DK91918381 T DK 91918381T DK 91918381 T DK91918381 T DK 91918381T DK 0552240 T3 DK0552240 T3 DK 0552240T3
Authority
DK
Denmark
Prior art keywords
new method
treating depression
depression
treating
compounds
Prior art date
Application number
DK91918381T
Other languages
Danish (da)
English (en)
Inventor
Jan David Wallace
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Application granted granted Critical
Publication of DK0552240T3 publication Critical patent/DK0552240T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
DK91918381T 1990-10-12 1991-10-02 Ny metode til behandling af depression DK0552240T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/596,270 US5025035A (en) 1990-10-12 1990-10-12 Method of treating depression
PCT/US1991/007330 WO1992006686A1 (en) 1990-10-12 1991-10-02 New method of treating depression

Publications (1)

Publication Number Publication Date
DK0552240T3 true DK0552240T3 (da) 1998-11-23

Family

ID=24386662

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91918381T DK0552240T3 (da) 1990-10-12 1991-10-02 Ny metode til behandling af depression

Country Status (11)

Country Link
US (1) US5025035A (es)
EP (1) EP0552240B1 (es)
JP (1) JP3192141B2 (es)
AT (1) ATE164065T1 (es)
CA (1) CA2092416A1 (es)
DE (1) DE69129115T2 (es)
DK (1) DK0552240T3 (es)
ES (1) ES2116298T3 (es)
GR (1) GR3026519T3 (es)
MX (1) MX9101526A (es)
WO (1) WO1992006686A1 (es)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5025035A (en) * 1990-10-12 1991-06-18 Warner-Lambert Company Method of treating depression
US5510381A (en) * 1995-05-15 1996-04-23 Warner-Lambert Company Method of treatment of mania and bipolar disorder
NZ331143A (en) * 1996-03-14 2001-06-29 Warner Lambert Co Substituted cyclic amino acids as pharmaceutical agents
US6372792B1 (en) 1996-04-26 2002-04-16 Guy Chouinard Method for treating anxiety, anxiety disorders and insomnia
CN1094757C (zh) 1996-07-24 2002-11-27 沃尼尔·朗伯公司 用于治疗疼痛的异丁基γ－氨基丁酸及其衍生物
US6194459B1 (en) 1997-08-19 2001-02-27 Warner-Lambert Company Methods for treating physiological conditions associated with the use, or sequelae of use, of cocaine or other psychomotors stimulants
AU9318398A (en) 1997-10-07 1999-04-27 Warner-Lambert Company Process for preparing a cyclic amino acid anticonvulsant compound
PL199794B1 (pl) 1997-10-27 2008-10-31 Warner Lambert Co Związki pośrednie do wytwarzania pochodnych cyklicznych aminokwasów
WO1999059572A1 (en) * 1998-05-15 1999-11-25 Warner-Lambert Company Gamma-aminobutyric acid derivatives containing, solid compositions and process for preparing the same
PL204921B1 (pl) 1998-05-15 2010-02-26 Warner Lambert Co Stabilizowana kompozycja farmaceutyczna zawierająca 4-amino-3-podstawioną pochodną kwasu butanowego i α-aminokwas oraz sposób jej wytwarzania
US6992109B1 (en) * 1999-04-08 2006-01-31 Segal Catherine A Method for the treatment of incontinence
EP1169060B1 (en) * 1999-04-09 2005-08-31 Euro-Celtique S.A. Sodium channel blocker compositions and the use thereof
HUP0200733A3 (en) * 1999-04-09 2003-04-28 Warner Lambert Co Combinations of gaba analogs and tricyclic compounds to treat depression
AP2002002501A0 (en) * 1999-10-07 2002-06-30 Warner Lambert Co Synergistic combinations of an NK1 receptor antagonist and a gaba structural analog.
WO2001097612A1 (en) 2000-06-16 2001-12-27 Teva Pharmaceutical Industries Ltd. Stable gabapentin containing more than 2o ppm of chlorine ion
EP1423168B1 (en) * 2001-09-03 2006-02-08 Newron Pharmaceuticals S.p.A. Pharmaceutical composition comprising gabapentin or an analogue thereof and an alpha-aminoamide and its analgesic use
US20030119908A1 (en) * 2001-12-21 2003-06-26 Zambon Group S.P.A. Stable gabapentin compositions
ITMI20012750A1 (it) 2001-12-21 2003-06-21 Procos Spa Processo per la produzione dell'acido 1-(amminometil)-cicloesil-acetico in forma pura
US20050181071A1 (en) * 2004-02-18 2005-08-18 Binder Michael R. Method for the treatment of clinical depression
AU2005282028B2 (en) * 2004-09-10 2011-03-24 Newron Pharmaceuticals S.P.A. (halobenzyloxy) benzylamino-propanamides as sodium and/or calcium channel selective modulators
WO2011151708A1 (en) 2010-06-01 2011-12-08 Rubicon Research Private Limited Gastroretentive dosage forms of gaba analogs
EP2923694B1 (en) 2014-03-27 2018-11-14 Sanovel Ilac Sanayi ve Ticaret A.S. Oral liquid pharmaceutical solution of gabapentin

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4087544A (en) * 1974-12-21 1978-05-02 Warner-Lambert Company Treatment of cranial dysfunctions using novel cyclic amino acids
DE2460891C2 (de) * 1974-12-21 1982-09-23 Gödecke AG, 1000 Berlin 1-Aminomethyl-1-cycloalkanessigsäuren und deren Ester, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel
US5084479A (en) * 1990-01-02 1992-01-28 Warner-Lambert Company Novel methods for treating neurodegenerative diseases
US5025035A (en) * 1990-10-12 1991-06-18 Warner-Lambert Company Method of treating depression

Also Published As

Publication number Publication date
US5025035A (en) 1991-06-18
JP3192141B2 (ja) 2001-07-23
DE69129115D1 (de) 1998-04-23
EP0552240A4 (en) 1993-09-01
DE69129115T2 (de) 1998-07-16
EP0552240B1 (en) 1998-03-18
GR3026519T3 (en) 1998-07-31
JPH06502148A (ja) 1994-03-10
CA2092416A1 (en) 1992-04-13
MX9101526A (es) 1992-06-05
WO1992006686A1 (en) 1992-04-30
ES2116298T3 (es) 1998-07-16
EP0552240A1 (en) 1993-07-28
ATE164065T1 (de) 1998-04-15

Similar Documents

Publication Publication Date Title
DK0552240T3 (da) Ny metode til behandling af depression
ATE33558T1 (de) Stabilisierung von influenzavirusimpfstoffen.
DK607689D0 (da) Fremgangsmaade til behandling af laeder
DK283881A (da) Fremgangsmaade til fremstilling af pyrazinyl1,2,4-oxadiazol-5-oner
ES2054747T3 (es) Nuevos antidepresivos.
DE59209129D1 (de) Verwendung von Antikörper enthaltenden Präparationen zur Immunsuppression
EA200000196A1 (ru) Универсальная плазма крови
DK356785D0 (da) Fremgangsmaade til inhibering af carbamylering ved behandling af peptider
ATE204851T1 (de) Verfahren zur herstellung von retrovial protease hemmenden zwischenprodukten
ES539382A0 (es) Procedimiento para la determinacion de fibrina
DK0743060T3 (da) Anvendelse af tandplejemidler indeholdende bovint colostrum
DE69131657D1 (de) Verfahren zur industriellen Herstellung von 4-Chloro-3-sulfamoyl-N-(2,3-dihydro-2-methyl-1H-indol-1-yl)-Benzamid
ES2236703T3 (es) Uso de metodos para identificar oligopeptidos de señal hidrofilos.
DE68912809T2 (de) Verfahren zur Herstellung von Bis(2,2,6,6-tetramethyl-4-piperidyl)amin.
DE3765784D1 (de) Zusammensetzung von aminosaeuren.
DE68903208T2 (de) Verfahren zur thermischen behandlung von laktoferrin.
DK192890D0 (da) 24r-scumnol, fremgangsmaade til fremstilling heraf samt anvendelse af samme
DK0673441T3 (da) Fremgangsmåde til kasein-overfladebehandling af læder
DK0854862T3 (da) Fremgangsmåde til fremstillingen af en aktiveret aminosyre
ATE82124T1 (de) Anwendung von n-(2-(diaethylamino)aethyl>-2-methoxy-4((1-h-4,5ihydro-2-imidazolyl)amino>-5- chlorobenzamid als anxiolytisches und antipsychotisches mittel.
DK205188D0 (da) Proteinprotease-inhibitorer af streptomyces
DK0779297T3 (da) Antigene peptider med glycinsubstitutioner
DE69112758D1 (de) Herstellung von Aminonitrilen.
DK661388A (da) Fremgangsmaade til fremstilling af thiophenforbindelser
ATE110385T1 (de) Derivate von aminocarboxylsäure.